ASIANET : World Experts Meet to Share Alzheimer's Strategies

Press Releases »

World Experts Meet to Share Alzheimer's Strategies

Latest news on development of a potential Alzheimer's vaccine to be presented

Tuesday, July 11

View webcasts and embargoed press releases at http://www.alzheimer2000.org

(webcast times and dates to be announced); Check the online program (http://www.alzheimer2000.org/program) or contact the Alzheimer's Association to identify researchers from your country and learn more about their projects

WASHINGTON, June 26 /PRNewswire-AsiaNet/ -- International Alzheimer research, treatment and care leaders will meet in Washington, D.C., from July 9 through 18, for World Alzheimer Congress 2000, a forum for experts to share information and identify strategies designed to eliminate the disease.  The congress, hosted by the Alzheimer's Association (U.S.A.), Alzheimer's Disease International and the Alzheimer Society of Canada, is divided into three events:
Pivotal Research -- July 9-13
Pivotal Research will include more than 1,200 oral, poster and plenary
sessions covering research ranging from new therapeutics and imaging
techniques to a potential new vaccine.
Bridging Research and Care -- July 13-14
Bridging Research and Care will provide health care professionals the
latest information about diagnosing, treating and caring for individuals
with Alzheimer's and ways to communicate the diagnosis to them and their
families.
Creative Care -- July 15-18
Creative Care will bring together professional and family caregivers and
association staff members for the exchange of information about the unique
needs and most effective methods of caring for individuals with
Alzheimer's.
The Alzheimer's Association (U.S.A.) assumed leadership of the world's largest international conference on Alzheimer's disease, World Alzheimer Congress 2000.  Over a 10-day span, world leaders in Alzheimer research and care will unite in July 2000, marking the first time these Alzheimer specialists have come together for the vital purpose of sharing information on research and care to improve the lives of people affected by Alzheimer's disease.  This unique gathering of scientists, healthcare professionals and other specialists is the collaborative effort of the Alzheimer's Association (U.S.A.), Alzheimer's Disease International, and Alzheimer Society of Canada. For more information about World Alzheimer Congress 2000, contact Julie Miller at 312-335-5776 or Nicolle Heller at 312-335-4037, or visit the website at http://www.alzheimer2000.org.

CONTACT:  Julie Miller, 312-335-5776, or [email protected], or Nicolle Heller, 312-335-4037, or [email protected], both of Alzheimer's Association (U.S.A.).

SOURCE:  Alzheimer's Association

CONTACT:  Julie Miller, 312-335-5776, or [email protected], or Nicolle Heller, 312-335-4037, or [email protected], both of Alzheimer's Association (U.S.A.)

Web site:  http://www.alzheimer2000.org -END-



ข่าวthe Alzheimer+PRNewswireวันนี้

ADVANCEMENTS IN TREATMENT, DIAGNOSIS AND RISK REDUCTION STRATEGIES HIGHLIGHTED AT ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE

New research reported at the Alzheimer's Association International Conference(R) (AAIC(R)) 2023 covered the breadth of Alzheimer's disease and dementia research, including advancements in treatment, early and accurate diagnosis, and our understanding of risk factors for Alzheimer's and other dementias. AAIC is the premier annual forum for presentation and discussion of the latest Alzheimer's and dementia research. This year's conference took place both virtually and in-person in Amsterdam,

ALZHEIMER'S ASSOCIATION STATEMENT ON DONANEMAB PHASE 3 DATA REPORTED AT AAIC 2023

The data reported today by Eli Lilly from the TRAILBLAZER-ALZ 2 clinical trial of donanemab in early symptomatic Alzheimer's disease demonstrate an important advancement in Alzheimer's research and treatment. The full...

HISTORY OF HYPERTENSIVE DISORDERS DURING PREGNANCY LINKED TO INCREASED RISK OF DEMENTIA

Experiences of high blood pressure disorders during pregnancy are associated with an increased risk of vascular dementia and accelerated brain aging, according to studies reported today at the Alzheimer's...

HIGHLIGHTS FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2022

New research reported at the Alzheimer's Association International Conference(R) (AAIC(R) ) 2022 covered the breadth of Alzheimer's and dementia research, including the basic biology of aging and the brain, risk factors and...

LOWER SOCIOECONOMIC STATUS IN CHILDHOOD, PERSISTENT LOW WAGES LINKED TO RISK FOR DEMENTIA AND FASTER MEMORY DECLINE

Socioeconomic deprivation, including neighborhood disadvantages and persistent low wages, are associated with higher dementia risk, lower cognitive performance and faster memory decline...

EXPERIENCES OF RACISM ASSOCIATED WITH POOR MEMORY, INCREASED COGNITIVE DECLINE

Experiences of structural, interpersonal and institutional racism are associated with lower memory scores and worse cognition in midlife and old age, especially among Black individuals, according to studies reported today...

PERSISTENT LOSS OF SMELL DUE TO COVID-19 CLOSELY CONNECTED TO LONG-LASTING COGNITIVE PROBLEMS

FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2022 Also, ICU Stay May Double Risk of Dementia in Older Adults New insights into factors that may predict, increase or protect against the impact of...

Highlights From The Alzheimer's Association International Conference 2021

Research presented at the Alzheimer's Association International Conference(R) (AAIC(R) ) 2021 suggests COVID-19 is associated with long-term cognitive dysfunction and acceleration of Alzheimer's disease pathology and symptoms....

COVID-19 Associated With Long-Term Cognitive Dysfunction, Acceleration Of Alzheimer's Symptoms

Much has been learned about SARS-CoV-2, the virus that causes the novel coronavirus, since the beginning of the COVID-19 pandemic. However, questions remain about the long-term impact of the virus on our...

Global Dementia Cases Forecasted To Triple By 2050

—New analysis shows a decrease in prevalence due to education countered by increase due to heart health risk factors Positive trends in global education access are expected to decrease dementia prevalence worldwide by 6.2 million cases by the year...